New COPD and asthma treatments jostle for market space
October 6, 2010Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma
Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …
Uncertainty over new cancer fund
October 6, 2010Sales and Marketing Cancer, NHS, government
The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …
Janssen leads the pack at PM Society Digital Awards
October 6, 2010Medical Communications Janssen, PM Society Digital Awards, disease awareness campaigns, pm society
Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …
New Commercial Realities – Part 4 Key implications of this changing industry landscape for pharmaceutical commercial operations – governance
October 5, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
Chris Brinsmead joins the Board of Kinapse
October 5, 2010Kinapse
London, UKThe Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a …
GSK takes stake in biotech spin-out
October 5, 2010Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding
GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …
Elan debuts manufacturing services business
October 5, 2010Manufacturing and Production Elan
Irish pharmaceutical company Elan marked its official entry into the solid dose contract manufacturing sector today at the ongoing CPhI …
Recipharm buys Abbott plant to enter Spanish market
October 5, 2010Manufacturing and Production Abbott, Recipharm, Solvay
Swedish contract development and manufacturing services company Recipharm has agreed to buy a facility in Parets del Valles, Spain, from …
Digital Pharma: Pfizer socialises pain campaign
October 5, 2010Medical Communications Digital Pharma blog, Facebook, Flickr, Pfizer, Twitter, social media
Pfizer is campaigning for better care for people suffering from chronic pain and has turned to social media to galvanise …
Svend Andersen to lead Hospira in Europe
October 5, 2010Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing
US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …
Talking R&D: Evolving technical standards
October 5, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions
The European Union (EU) Module 1 specification works in parallel with the ICH eCTD Specification. It was first introduced in …
Sanofi makes hostile offer for Genzyme
October 4, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …
Managing the Franchise
October 4, 2010Sales and Marketing branding, marketing, product portfolio
Commercial managers who are responsible for a number of brands face a constant dilemma in choosing where across the franchise …
Mitsui boosts contract manufacturing business
October 4, 2010Manufacturing and Production API, Arch Pharmalabs, India, Mitsui
Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …
Further expansion for Doctors.net.uk pharma team
October 4, 2010Sales and Marketing Doctors.net.uk, GPs, communications, doctors, pharma marketing
New hires to support and drive rapid growth
GSK drops herpes vaccine
October 4, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health
Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …
David Gallagher to head up IPHA
October 4, 2010Sales and Marketing IPHA, appointment, sales and marketing
Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …
Talking R&D: US regulatory guidelines
October 4, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD submissions
Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …
Zydus Nycomed’s API plant to start production soon
October 4, 2010Manufacturing and Production API, India, Nycomed, Zydus Cadila
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
AZ-BMS diabetes drug impresses in phase III trials
October 1, 2010Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes
AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
